IP Library › Granted Patent US 8,618,174
Granted Patent B2
US 8,618,174 · App. 13/235,787 · Granted Dec 31, 2013

Synergistic combinations comprising a renin inhibitor for cardiovascular diseases

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,618,174
App. No.
13/235,787
Granted
Dec 31, 2013
Kind
B2
Abstract

The invention relates to a combination comprising the renin inhibitor of formula (I) or a pharmaceutically acceptable salt thereof.

Claims (4)

1. A pharmaceutical composition comprising the renin inhibitor of formula (I)

as a hemi-fumarate, hydrochlorothiazide, amlodipine or a pharmaceutically acceptable salt thereof, and a carrier.

2. The composition according to claim 1 for the treatment of hypertension.

3. The composition according to claim 1 for simultaneous, separate or sequential use.

Assignments (3)
CHANGE OF ADDRESS Recorded Mar 21, 2017
From: NODEN PHARMA DAC
To: NODEN PHARMA DAC
Reel/Frame 042084/0980 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNEE'S ADDRESS PREVIOUSLY RECORDED ON REEL 039481 FRAME 0233. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Aug 29, 2016
From: NOVARTIS AG; NOVARTIS PHARMA AG; SPEEDEL HOLDING AG
To: NODEN PHARMA DAC
Reel/Frame 040003/0579 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 26, 2016
From: NOVARTIS AG; NOVARTIS PHARMA AG; SPEEDEL HOLDING AG
To: NODEN PHARMA DAC
Reel/Frame 039481/0233 →